Presentation is loading. Please wait.

Presentation is loading. Please wait.

Suppl. Fig.1 KEGG B-cell receptor signaling pathway. Added by YLW.

Published byAngela Webster Modified over 8 years ago

Similar presentations

Presentation on theme: "Suppl. Fig.1 KEGG B-cell receptor signaling pathway. Added by YLW."— Presentation transcript:

1 Suppl. Fig.1 KEGG B-cell receptor signaling pathway. Added by YLW

2 NTScrsiBTKNTScrsiBTK CLL162CLL239 BTK GAPDH Suppl. Fig.2. Genetic knock-down of BTK. A. Knock-down of BTK with siRNA was initially validated by immunoblotting in primary CLL cases (CLL162 and CLL239). NT, no treatment; Scr, scrambled siRNA control. siBTK, siRNA specific for BTK. B. A flow cytometric assay was later validated against Immunoblotting to determine the levels of total BTK protein. The assay was used in this particular patient, CLL015, to assess the BTK knockdown efficiency for the proliferation assay shown in Fig. 4A. Iso, isotype control. Scr, scrambled siRNA control. siBTK, siRNA specific for BTK. Iso scr siBTK Cell Number Total-BTK CLL015 A B

3 3 WT Mutant Suppl. Fig.3. Structural modeling of dasatinib in complex with WT BTK or BTK C481S.

4 4 18.7% 7.05% 8.12% 4.25% 0.36% No drug 250nM ibrutinib 250nM Idelalisib 1000nM Idelalisib 5000nM Idelalisib 7-AAD BrdU Suppl. Fig.4. Idelalisib has the potential to overcome ibrutinib resistance. Ibrutinib-resistant Relapsed s1 specimen was tested against varying doses of idelalicib (C max : ~6  M). Left panel, percentages of BrdU + CLL cells. Treatment conditions were indicated. Right panel, proliferation rates (%) were normalized to no drug control (100%). 100 Normalized Proliferate Rate (%) no drug 1.9% 37.7% 250nM ibrutinib 250nM1000nM5000nM 43.4% 22.7% idelalicib

Download ppt "Suppl. Fig.1 KEGG B-cell receptor signaling pathway. Added by YLW."

Similar presentations

A b Supp. Figure 1: Anoikis-resistance of MDA-MB-231 is dependent on PI3Kγ (a) Cells were prevented from attaching for 48 hours in the presence of DMSO,

A b Supp. Figure 1: Anoikis-resistance of MDA-MB-231 is dependent on PI3Kγ (a) Cells were prevented from attaching for 48 hours in the presence of DMSO,
NEGpre-221 pre-222pre-221/222 NEG DMSO 100 nM Fulvestrant for 72h Figure S1. Cell morphology of MCF7 cells after treatment with fulvestrant, with or without.

NEGpre-221 pre-222pre-221/222 NEG DMSO 100 nM Fulvestrant for 72h Figure S1. Cell morphology of MCF7 cells after treatment with fulvestrant, with or without.
Supplementary Fig. 1. Transcriptome analysis of MENX-associated pituitary adenomas and and comparison with human studies. Control samples from wild-type.

Supplementary Fig. 1. Transcriptome analysis of MENX-associated pituitary adenomas and and comparison with human studies. Control samples from wild-type.
Ibrutinib: First-in Class Inhibitor of BTK  Forms a specific and irreversible bond with cysteine-481 in BTK  Highly potent BTK inhibition at IC 50 =

Ibrutinib: First-in Class Inhibitor of BTK  Forms a specific and irreversible bond with cysteine-481 in BTK  Highly potent BTK inhibition at IC 50 =
Mechanisms of Ibrutinib Sensitivity and Resistance in CLL Y. Lynn Wang, MD, PhD, FCAP Dept. of Pathology University of Chicago October 24, 2014.

Mechanisms of Ibrutinib Sensitivity and Resistance in CLL Y. Lynn Wang, MD, PhD, FCAP Dept. of Pathology University of Chicago October 24, 2014.
Lopez de Silanes et al. Suppl-Fig.1 0 10 50 100 246 DNMT3b in HuR siRNA cells t 1/2 (Untr)=2.13 h t 1/2 (Cispl)=3.27 h 0246 0 t 1/2 (Cispl)>8 h t 1/2 (Untr)>8.

Lopez de Silanes et al. Suppl-Fig DNMT3b in HuR siRNA cells t 1/2 (Untr)=2.13 h t 1/2 (Cispl)=3.27 h t 1/2 (Cispl)>8 h t 1/2 (Untr)>8.
Additional File 1 A. p38 (38 kDa) shRNA Control p53 (53 kDa) shRNA p53 B. Untransfected cells Relative cell no. GFP- vector GFP-Ras G12V Fluorescence Additional.

Additional File 1 A. p38 (38 kDa) shRNA Control p53 (53 kDa) shRNA p53 B. Untransfected cells Relative cell no. GFP- vector GFP-Ras G12V Fluorescence Additional.
B Supplementary Fig S1. (A) ZR75- and MCF7-PELP1 knockdown cells were generated as described in methods section. Pooled colonies were analyzed for PELP1.

B Supplementary Fig S1. (A) ZR75- and MCF7-PELP1 knockdown cells were generated as described in methods section. Pooled colonies were analyzed for PELP1.
Supplementary Figure S1 FPKM ESRP1ESRP2 normaltumor Supplementary Figure S1. ESRP1 and ESRP2 mRNA expression in 65 normal kidney samples and 474 ccRCC.

Supplementary Figure S1 FPKM ESRP1ESRP2 normaltumor Supplementary Figure S1. ESRP1 and ESRP2 mRNA expression in 65 normal kidney samples and 474 ccRCC.
Supplementary Table S1. List of chemical inhibitors utilized in the current study. Supplementary Information.

Supplementary Table S1. List of chemical inhibitors utilized in the current study. Supplementary Information.
Supplemental Materials: Anti-apoptotic BCL-2 family proteins as 5-Azacytidine sensitizing targets and determinants of response in myeloid malignancies.

Supplemental Materials: Anti-apoptotic BCL-2 family proteins as 5-Azacytidine sensitizing targets and determinants of response in myeloid malignancies.
Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.

Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.
G1 synchronous cells released at T = 0

G1 synchronous cells released at T = 0
Nm23-H1 Regulates Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells via Arf6-Rac1 Signaling Axis Cell Physiol Biochem 2013;32:533-541 - DOI:10.1159/000354457.

Nm23-H1 Regulates Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells via Arf6-Rac1 Signaling Axis Cell Physiol Biochem 2013;32: DOI: /
The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR) Cell.

The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR) Cell.
Involvement of Wnt Signaling in Dermal Fibroblasts

Involvement of Wnt Signaling in Dermal Fibroblasts
Chemosensitivity linked to p73 function

Chemosensitivity linked to p73 function
Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.

Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.
Current and Future Goals in the Treatment of Relapsed CLL

Current and Future Goals in the Treatment of Relapsed CLL
HDAC1 is an integral component of the Microprocessor complex and modifies its affinity to primary miRNA transcripts. HDAC1 is an integral component of.

HDAC1 is an integral component of the Microprocessor complex and modifies its affinity to primary miRNA transcripts. HDAC1 is an integral component of.

Similar presentations

Ads by Google